Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.
Donohue JF, Fogarty C, Lötvall J, Mahler DA, Worth H, Yorgancioglu A, Iqbal A, Swales J, Owen R, Higgins M, Kramer B; INHANCE Study Investigators. Donohue JF, et al. Among authors: owen r. Am J Respir Crit Care Med. 2010 Jul 15;182(2):155-62. doi: 10.1164/rccm.200910-1500OC. Epub 2010 May 12. Am J Respir Crit Care Med. 2010. PMID: 20463178 Clinical Trial.
Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison.
Kornmann O, Dahl R, Centanni S, Dogra A, Owen R, Lassen C, Kramer B; INLIGHT-2 (Indacaterol Efficacy Evaluation Using 150-µg Doses with COPD Patients) study investigators. Kornmann O, et al. Among authors: owen r. Eur Respir J. 2011 Feb;37(2):273-9. doi: 10.1183/09031936.00045810. Epub 2010 Aug 6. Eur Respir J. 2011. PMID: 20693243 Free article. Clinical Trial.
Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.
Dahl R, Chung KF, Buhl R, Magnussen H, Nonikov V, Jack D, Bleasdale P, Owen R, Higgins M, Kramer B; INVOLVE (INdacaterol: Value in COPD: Longer Term Validation of Efficacy and Safety) Study Investigators. Dahl R, et al. Among authors: owen r. Thorax. 2010 Jun;65(6):473-9. doi: 10.1136/thx.2009.125435. Thorax. 2010. PMID: 20522841 Clinical Trial.
Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: a randomized, crossover study.
Laforce C, Aumann J, de Teresa Parreño L, Iqbal A, Young D, Owen R, Higgins M, Kramer B; INTEGRAL Study Investigators. Laforce C, et al. Among authors: owen r. Pulm Pharmacol Ther. 2011 Feb;24(1):162-8. doi: 10.1016/j.pupt.2010.06.005. Epub 2010 Jul 7. Pulm Pharmacol Ther. 2011. PMID: 20619353 Clinical Trial.
2,214 results